Behavioral Neurobiology division is the research unit of the department with a group of neuroscientists and clinicians who are focused on studying the neurobiology of schizophrenia, mood disorders, neurodevelopmental diseases, neurodegenerative diseases, and circadian regulations related to mental disorders.

The mission of Behavioral Neurobiology division is to translate neurobiological findings into improved diagnosis, treatment, and management of these mental illnesses.

Faculty in the division address important research questions by using methods of cellular and molecular biology, neurochemistry, neuroimmunology, psychopharmacology, pharmacogenetics and genomics, human postmortem neuroanatomy, and human brain imaging. The division also provides its faculty on-site support, via its clinical research office and neuroimaging laboratory, to develop translational approaches and to test clinical significance of neurobiological research findings. The brain bank and biological repository are integrated core facility of the division, aiming to provide a broad range of neurobiological materials for research of mental illnesses.

Pursuing innovative research, providing state-of-the-art treatment of psychiatric disorders, and training the next-generation of psychiatrists

The Department of Psychiatry at the University of Alabama at Birmingham is advancing the understanding of psychiatric disorders through an integrated approach of research, education, and patient care. Collaboration between laboratory research and clinical areas facilitate translational integration of research findings, with the goal of developing innovative and novel clinical interventions.


Advancing knowledge discovery in schizophrenia, depression and bipolar disorder, neurodegenerative disorders, substance abuse, and psychiatric disorders of childhood and the elderly


Developing future academic leaders, researched-focused clinical investigators and clinical psychiatrists through residency and fellowship training programs

Patient Care

 Providing state-of-the-art care through a 90-bed inpatient facilty, community-based clinics, and other patient focused programs